Skip to main content
    P

    Passage Bio Inc (PASG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.13
    -0.12 (-2.82%)

    Market Cap: $13.68M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    54%(15/28)
    Avg Surprise
    +3.77%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$2.60
    RangeN/A
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$2.33
    Range-$4.06 - -$1.01
    6 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$2.02-15.2%
    60d ago-$2.03-14.6%
    30d ago-$1.93-20.8%
    7d ago-$2.08-11.9%
    Current-$2.33
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-212.30%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.00xQuick Ratio1.00x
    Trading Statistics
    Beta1.49Avg Volume15.27K
    52-Week High$20.0052-Week Low$3.29

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 0.8% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 56.9, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$3.79
    SMA 20$3.62
    SMA 50$4.10
    SMA 200$5.78
    EMA 10$3.87
    EMA 20$3.79
    EMA 50$4.00
    EMA 200$5.47

    MACD

    Line: 0.03Signal: -0.09Hist: 0.12

    ADX

    ADX: 27.0+DI: 24.7-DI: 13.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down48.0
    PSAR$3.44

    Bollinger Bands

    Upper Band$4.21
    Lower Band$3.03
    %B Position3266%(Upper)
    Band Width0.93

    RSI (14-Day)

    Neutral
    56.9

    Momentum Oscillators

    Stoch %K92.4
    Stoch %D91.7
    Williams %R-12.6
    ROC (10d)24.4%
    Momentum0.81
    CCI (20d)167.0
    MFI (14d)65.2

    Volatility Measures

    ATR (14d)$0.34(8.3%)
    StdDev (20d)0.30
    Hist Vol94.0%(High)

    Volume Flow

    VWAP$4.06
    OBV3.8M
    AD Line6.0B
    CMF (20d)0.033

    Volume Metrics

    Avg Vol (20d)15.5K
    Vol Ratio1.1x
    VWMA (20d)$3.66

    Pivot Points

    R3$4.65
    R2$4.45
    R1$4.35
    Pivot Point$4.15
    S1$4.05
    S2$3.85
    S3$3.75

    Advanced Oscillators

    TSI1.74
    Ultimate Osc65.9
    KST-54.86

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about PASG

    News

    PASG Valuation

    PASG Profitability: Margins, ROIC and FCF

    Passage Bio (PASG) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -212.3%
    PASG financial statements

    Passage Bio Competitors

    The companies most similar to Passage Bio (PASG) include Psyence Biomedical Ltd. Common Shares, Cyclerion Therapeutics and Biovie.

    Sector: Healthcare

    Companies most similar to Passage Bio

    PASG Analyst Ratings

    Passage Bio (PASG) has a Hold consensus from 3 analysts: 1 Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell.

    Consensus
    Hold
    Analysts
    3
    Strong Buy
    0
    Buy
    1
    Hold
    2
    Sell
    0
    Strong Sell
    0
    PASG stock forecast

    PASG Earnings: Beat Rate and Next Report

    Passage Bio (PASG) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 1, 2027.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    5.0%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$2.60
    PASG earnings history

    PASG Earnings Date

    PASG reports Mar 1, 2027. The date is estimated.

    PASG ETF Holders

    See insider activity

    Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About PASG

    When does PASG report earnings?

    Passage Bio Inc (PASG) is expected to report earnings on Mar 1, 2027.

    Does PASG pay dividends?

    Passage Bio Inc (PASG) does not currently pay a regular dividend.

    What is PASG's market cap?

    Passage Bio Inc (PASG) has a market capitalization of $13.68M with a current stock price of $4.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.